← brief for 2026-09-08 · Slowing decline

Finerenone in Asian patients with diabetic kidney disease: evaluating the evidence for "better efficacy".

Article No results yet Peer reviewed

Key takeaways

This article asks whether finerenone works better in Asian patients with diabetic kidney disease than in other groups. Finerenone is an approved pill that blocks a hormone signal which drives kidney scarring and inflammation, and it protects both kidneys and heart. Diabetes is now the leading cause of kidney failure across the Asia Pacific region. The authors weigh up trial evidence that already exists rather than running a new study, so there are no new results.

Who did this work

Gong S · Ji L

Source

Article · PubMed, the drug frontier · 2026 Aug 20
https://pubmed.ncbi.nlm.nih.gov/42707964/